We’re Apostrophe, a healthcare technology platform reimagining what dermatology should look like in the 21st century. Apostrophe’s vertically-integrated platform powers a bespoke experience for every patient, from digital diagnosis to medication delivery, to ongoing care. Apostrophe is the only company to combine a nationwide network of dermatologists and a prescription compounding facility to provide world-class dermatology care at a fraction of the cost or hassle of the traditional healthcare system.
In July of 2021, Apostrophe was acquired by Hims and Hers, Inc. (ticker: HIMS), the multi-specialty telehealth platform. Apostrophe is a fully autonomous startup brand under H&H, now with the resources of a multi-billion dollar public company to scale our revolutionary offerings to the stratosphere (don’t forget your SPF!).
